Recombinant Mouse Thrombospondin-1 (TSP-1) – Purified
Recombinant Mouse Thrombospondin-1 (TSP-1) – Purified
Product No.: T1009
- -
- -
| Alternate Names THBS; THBS1; THBS-1; Thrombospondin 1; Thrombospondin1; Thrombospondin-1; Thrombospondin-1p180; TSP-1; TSP1; Thrombospondin-1; TSPTSP-1 Product Type Recombinant Protein Expression Host HEK-293 Cells |
- -
- -
| Select Product Size | Qty Max: Min: 1 Step: 1 $495.00 |
- -
- -
BackgroundThrombospondin-1 (TSP-1, encoded by the THBS1 gene) is a 150–180 kDa calcium-sensitive, matricellular glycoprotein that is secreted into the extracellular matrix (ECM) as a complex disulfide-linked homotrimer (totaling ~450 kDa). Native TSP-1 is widely produced by platelets, endothelial cells, fibroblasts, and immune cells. It features a highly modular structure, including an N-terminal domain, a von Willebrand factor type C domain, multiple TSP type 1, 2, and 3 repeats, and a C-terminal lectin domain. Because of this multimodular architecture, TSP-1 acts as a dynamic biological modulator, regulating cellular behavior by interacting with a wide array of cell-surface receptors (e.g., CD36, CD47, integrins), growth factors, and other ECM components. Biological Functions and Signaling Pathways TSP-1 is a highly pleiotropic protein with a well-established role as a potent endogenous inhibitor of angiogenesis. By binding to the CD36 receptor on vascular endothelial cells, TSP-1 neutralizes VEGF signaling, inhibits endothelial cell proliferation and migration, and induces cell apoptosis. Beyond its anti-angiogenic properties, TSP-1 is a primary physiological activator of latent Transforming Growth Factor-beta (TGF-β), binding to the latency-associated peptide (LAP) to release active TGF-β, thereby driving tissue repair, remodeling, and localized fibrotic responses. Furthermore, TSP-1 binds to CD47 to dampen adaptive immune responses by inhibiting T-cell receptor (TCR) signaling and promoting regulatory T cell differentiation. It also plays vital roles in platelet aggregation, wound healing, and macrophage-mediated clearance of apoptotic cells. The HEK293 Expression Advantage Leinco’s Recombinant Mouse TSP-1 is produced in a mammalian human embryonic kidney (HEK293) expression system. Because mature TSP-1 is a large, heavily glycosylated, and complex homotrimeric protein, the choice of expression system is critical for downstream performance. Superior to Bacterial Systems: Bacterial expression systems (such as E. coli) cannot perform glycosylation or assemble complex multimeric structures, limiting them to producing truncated, non-glycosylated protein fragments (e.g., amino acids 19–350). A Premier Mammalian Alternative: While some competitive full-length proteins are produced in murine myeloma (NS0) cells, HEK293 cells are globally recognized for highly efficient, stable production of complex proteins without the risk of adding immunogenic non-human glycans (such as α-Gal) that NS0 cells sometimes attach. Expression in HEK293 cells ensures the incorporation of native-like post-translational modifications, proper disulfide-linked trimerization, and accurate protein folding. This results in a functionally active, full-length protein that closely mimics natural murine TSP-1, making it the ideal choice for sensitive in vitro cell adhesion assays, receptor-binding studies, and signaling pathway research. Protein DetailsSpecies Mouse Format Purified No Carrier Protein Purity ≥95% by SDS Page Biological Activity ECM regulation Protein Accession No. NP_035710 Amino Acid Sequence [Mouse Thrombospondin-1 (Asn19-Ser1170)]-GGGSGGGSGGGS-6xHis State of Matter Lyophilized Predicted Molecular Mass 130-155 kDa, reducing conditions Formulation This recombinant protein is aseptically packaged (0.2um filtered) and formulated in 0.01 M PBS (phosphate buffered saline) (150 mM NaCl) pH 7.0 - 7.5 with no carrier protein, potassium, calcium or preservatives added before lyophilization. Reconstitution Reconstitute at 0.1 mg/ml using PBS (Phosphate Buffered Saline). Gently mix by vortexing and/or inversion until fully dissolved. Centrifuge if necessary. Storage and Stability This lyophilized protein is stable for twelve months when stored at -20°C to -70°C. After aseptic reconstitution, this protein may be stored for one month at 2°C to 8°C or for three months at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. Country of Origin USA Shipping Dry Ice Ligand/Receptor Fibrinogen, fibronectin, collagen type V/VII, integrin alpha-V/beta-1 Species Mouse Regulatory Status Research Use Only NCBI Gene Bank UniProt.org P35441 Other Applications Reported In Literature ? ELISA, WB References & Citations1. Iozzo RV. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem. 1998;67:609-52. doi: 10.1146/annurev.biochem.67.1.609. PMID: 9759499. 2. Roberts DD, Miller TW, Rogers NM, Yao M, Isenberg JS. The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47. Matrix Biol. 2012 Apr;31(3):162-9. doi: 10.1016/j.matbio.2012.01.005. Epub 2012 Jan 14. PMID: 22266027; PMCID: PMC3295899. 3. Sweetwyne MT, Murphy-Ullrich JE. Thrombospondin1 in tissue repair and fibrosis: TGF-β-dependent and independent mechanisms. Matrix Biol. 2012 Apr;31(3):178-86. doi: 10.1016/j.matbio.2012.01.006. Epub 2012 Jan 14. PMID: 22266026; PMCID: PMC3295861. Certificate of AnalysisIMPORTANT Use lot specific datasheet for all technical information pertaining to this recombinant protein. |
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
